Published in Neurology on June 24, 2003
IgG1 antibodies to acetylcholine receptors in 'seronegative' myasthenia gravis. Brain (2008) 2.91
Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity. Lancet Neurol (2009) 2.86
Myasthenia gravis. Orphanet J Rare Dis (2007) 1.81
Anti-MuSK autoantibodies block binding of collagen Q to MuSK. Neurology (2011) 1.77
Induction of myasthenia by immunization against muscle-specific kinase. J Clin Invest (2006) 1.13
Clinical and serological study of myasthenia gravis in HuBei Province, China. J Neurol Neurosurg Psychiatry (2006) 1.10
The features of myasthenia gravis with autoantibodies to MuSK. J Neurol Neurosurg Psychiatry (2005) 1.08
Myasthenia gravis thymus: complement vulnerability of epithelial and myoid cells, complement attack on them, and correlations with autoantibody status. Am J Pathol (2007) 1.05
Antibodies against low-density lipoprotein receptor-related protein 4 induce myasthenia gravis. J Clin Invest (2013) 1.03
Pyridostigmine but not 3,4-diaminopyridine exacerbates ACh receptor loss and myasthenia induced in mice by muscle-specific kinase autoantibody. J Physiol (2013) 1.00
Muscle autoantibodies in myasthenia gravis: beyond diagnosis? Expert Rev Clin Immunol (2012) 0.98
Autoantibodies to agrin in myasthenia gravis patients. PLoS One (2014) 0.97
Effects of the ß2-adrenoceptor agonist, albuterol, in a mouse model of anti-MuSK myasthenia gravis. PLoS One (2014) 0.96
Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the Guidelines of the German Neurological Society. J Neurol (2016) 0.94
Ocular myasthenia: a rare presentation with MuSK antibody and bilateral extraocular muscle atrophy. Br J Ophthalmol (2007) 0.94
LRP4 is critical for neuromuscular junction maintenance. J Neurosci (2014) 0.93
Juvenile myasthenia gravis: a paediatric perspective. Autoimmune Dis (2011) 0.90
Acute severe animal model of anti-muscle-specific kinase myasthenia: combined postsynaptic and presynaptic changes. Arch Neurol (2011) 0.89
Autoimmune Myasthenia Gravis: Recommendations for Treatment and Immunologic Modulation. Curr Treat Options Neurol (2005) 0.89
Characterization of B cells in muscle-specific kinase antibody myasthenia gravis. Neurol Neuroimmunol Neuroinflamm (2015) 0.87
Epidemiology of myasthenia gravis with anti-muscle specific kinase antibodies in The Netherlands. J Neurol Neurosurg Psychiatry (2006) 0.87
Myasthenia gravis: a clinical-immunological update. J Neurol (2015) 0.85
Juvenile seropositive myasthenia gravis with anti-MuSK antibody after thymectomy. J Neurol (2009) 0.84
The role of muscle-specific tyrosine kinase (MuSK) and mystery of MuSK myasthenia gravis. J Anat (2013) 0.82
Comparison of muscle ultrastructure in myasthenia gravis with anti-MuSK and anti-AChR antibodies. J Neurol (2010) 0.82
B-cell-activating factor and autoimmune myasthenia gravis. Autoimmune Dis (2011) 0.82
Patterns and severity of neuromuscular transmission failure in seronegative myasthenia gravis. J Neurol Neurosurg Psychiatry (2005) 0.81
Stable expression of human muscle-specific kinase in HEp-2 M4 cells for automatic immunofluorescence diagnostics of myasthenia gravis. PLoS One (2014) 0.81
Biological implications of thymectomy for myasthenia gravis. Surg Today (2010) 0.81
Differential Cytokine Changes in Patients with Myasthenia Gravis with Antibodies against AChR and MuSK. PLoS One (2015) 0.80
MuSK myasthenia gravis as a manifestation of immune restoration disease in an HIV-positive patient. J Neurol (2015) 0.80
The emerging diversity of neuromuscular junction disorders. Acta Myol (2007) 0.80
Animal models of antimuscle-specific kinase myasthenia. Ann N Y Acad Sci (2012) 0.79
Clinically biphasic myasthenia gravis with both AChR and MuSK antibodies. J Neurol (2012) 0.78
Collagen Q and anti-MuSK autoantibody competitively suppress agrin/LRP4/MuSK signaling. Sci Rep (2015) 0.78
Muscle-specific receptor tyrosine kinase antibody positive myasthenia gravis current status. J Clin Neurol (2009) 0.78
Myasthenia gravis induced by autoantibodies against MuSK. Acta Myol (2007) 0.78
Anti-MuSK antibodies in a case of ocular myasthenia gravis. J Neurol Neurosurg Psychiatry (2006) 0.77
Autoantibodies in neuromuscular transmission disorders. Ann Indian Acad Neurol (2008) 0.77
Altered active zones, vesicle pools, nerve terminal conductivity, and morphology during experimental MuSK myasthenia gravis. PLoS One (2014) 0.77
Myasthenia gravis: Five new things. Neurol Clin Pract (2013) 0.76
MuSK-antibody positive pure ocular myasthenia gravis. J Neurol (2005) 0.76
Determination of the normative values of the masseter muscle by single-fiber electromyography in myasthenia gravis patients. Int J Clin Exp Med (2015) 0.75
Regulatory B Cells in Seropositive Myasthenia Gravis versus Healthy Controls. Front Neurol (2017) 0.75
Clinical Evaluation of Blepharoptosis: Distinguishing Age-Related Ptosis from Masquerade Conditions. Semin Plast Surg (2017) 0.75
Double Seronegative Myasthenia Gravis with Anti-LRP4 Antibodies Presenting with Dropped Head and Acute Respiratory Insufficiency. Intern Med (2016) 0.75
The Myotonic Plot Thickens: Electrical Myotonia in Antimuscle-Specific Kinase Myasthenia Gravis. Case Rep Neurol Med (2015) 0.75
Comorbid Human Immunodeficiency Virus (HIV) and Muscle-Specific Kinase (MuSK) Myasthenia Gravis: A Case Report and Literature Review. Am J Case Rep (2017) 0.75
Diagnostics of myasthenic syndromes: detection of anti-AChR and anti-MuSK antibodies. Neurol Sci (2017) 0.75
Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry (2004) 10.58
Changes in thymic function with age and during the treatment of HIV infection. Nature (1998) 10.27
Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays. Neurology (2012) 3.79
Viral RNA annealing activities of human immunodeficiency virus type 1 nucleocapsid protein require only peptide domains outside the zinc fingers. Proc Natl Acad Sci U S A (1992) 3.71
Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat Med (2001) 3.26
Potassium channel antibodies in two patients with reversible limbic encephalitis. Ann Neurol (2001) 3.06
Antibody to aquaporin-4 in the long-term course of neuromyelitis optica. Brain (2008) 2.96
Acquired neuromyotonia: evidence for autoantibodies directed against K+ channels of peripheral nerves. Ann Neurol (1995) 2.79
Sequence and structure of the serendipity locus of Drosophila melanogaster. A densely transcribed region including a blastoderm-specific gene. J Mol Biol (1985) 2.58
Limbic encephalitis as a precipitating event in adult-onset temporal lobe epilepsy. Neurology (2007) 2.55
Serum antibodies in epilepsy and seizure-associated disorders. Neurology (2005) 2.53
A Drosophila Minute gene encodes a ribosomal protein. Nature (1985) 2.53
Autoimmune aetiology for myasthenic (Eaton-Lambert) syndrome. Lancet (1981) 2.36
Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravis. Brain (1980) 2.36
ovo/svb integrates Wingless and DER pathways to control epidermis differentiation. Nature (1999) 2.32
Invited article: The ABPN maintenance of certification program for neurologists: past, present, and future. Neurology (2008) 2.31
Autoimmune aetiology for acquired neuromyotonia (Isaacs' syndrome) Lancet (1991) 2.28
Autoantibodies detected to expressed K+ channels are implicated in neuromyotonia. Ann Neurol (1997) 2.17
Anti-Ma and anti-Ta associated paraneoplastic neurological syndromes: 22 newly diagnosed patients and review of previous cases. J Neurol Neurosurg Psychiatry (2008) 2.16
Morvan's syndrome: peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels. Brain (2001) 2.14
Progressive encephalomyelitis, rigidity, and myoclonus: a novel glycine receptor antibody. Neurology (2008) 2.13
Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays. J Neurol Neurosurg Psychiatry (1985) 2.11
Mutations in eukaryotic 18S ribosomal RNA affect translational fidelity and resistance to aminoglycoside antibiotics. EMBO J (1994) 2.08
Immunotherapy-responsive seizure-like episodes with potassium channel antibodies. Neurology (2008) 2.06
P/Q type calcium-channel antibodies in paraneoplastic cerebellar degeneration with lung cancer. Neurology (2002) 2.05
Cricoid pressure: can protective force be sustained? Br J Anaesth (1998) 1.97
Progressive encephalomyelitis with rigidity and myoclonus: glycine and NMDA receptor antibodies. Neurology (2011) 1.93
Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients. Arch Neurol (2001) 1.90
Successful treatment of anti-N-methyl-D-aspartate receptor encephalitis presenting with catatonia. Arch Dis Child (2009) 1.84
Isolation of sequences that span the fragile X and identification of a fragile X-related CpG island. Science (1991) 1.82
Acetylcholine receptor antibody characteristics in myasthenia gravis. I. Patients with generalized myasthenia or disease restricted to ocular muscles. Clin Exp Immunol (1982) 1.78
NMO-IgG in the diagnosis of neuromyelitis optica. Neurology (2007) 1.77
Paraneoplastic myasthenic syndrome IgG inhibits 45Ca2+ flux in a human small cell carcinoma line. Nature (1985) 1.76
Prevention of autoimmune attack by targeting specific T-cell receptors in a severe combined immunodeficiency mouse model of myasthenia gravis. Ann Neurol (1999) 1.75
A somatically mutated human antiganglioside IgM antibody that induces experimental neuropathy in mice is encoded by the variable region heavy chain gene, V1-18. J Clin Invest (1996) 1.74
TFIIIA and homologous genes. The 'finger' proteins. Nucleic Acids Res (1986) 1.74
Hu and voltage-gated calcium channel (VGCC) antibodies related to the prognosis of small-cell lung cancer. J Clin Oncol (2004) 1.71
Passive transfer of Lambert-Eaton myasthenic syndrome with IgG from man to mouse depletes the presynaptic membrane active zones. Proc Natl Acad Sci U S A (1983) 1.71
Function of circulating antibody to acetylcholine receptor in myasthenia gravis: investigation by plasma exchange. Neurology (1978) 1.71
Serum factor in Miller-Fisher variant of Guillain-Barré syndrome and neurotransmitter release. Lancet (1994) 1.69
Trends in American Board of Psychiatry and Neurology specialties and neurologic subspecialties. Neurology (2010) 1.62
Brain abnormalities in Sjogren syndrome with recurrent CNS manifestations: association with neuromyelitis optica. Mult Scler (2009) 1.58
Management of suspected viral encephalitis in children - Association of British Neurologists and British Paediatric Allergy, Immunology and Infection Group national guidelines. J Infect (2011) 1.57
Incidence of serum anti-P/O-type and anti-N-type calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome. J Neurol Sci (1997) 1.56
Leukemia inhibitory factor, oncostatin M, IL-6, and stem cell factor mRNA expression in human thymus increases with age and is associated with thymic atrophy. J Immunol (2000) 1.55
Immunology of acetylcholine receptors in relation to myasthenia gravis. Physiol Rev (1980) 1.54
Acetylcholine receptor expression in human extraocular muscles and their susceptibility to myasthenia gravis. Ann Neurol (1997) 1.50
An improved diagnostic assay for Lambert-Eaton myasthenic syndrome. J Neurol Neurosurg Psychiatry (1995) 1.49
Pharmacokinetics and bronchial diffusion of single daily dose amikacin in cystic fibrosis patients. J Antimicrob Chemother (1997) 1.48
Trans-activation of the 5' to 3' viral DNA strand transfer by nucleocapsid protein during reverse transcription of HIV1 RNA. C R Acad Sci III (1993) 1.42
Diagnosis of the first two outbreaks of FMD in Ireland. Vet Rec (2001) 1.42
The COE transcription factor Collier is a mediator of short-range Hedgehog-induced patterning of the Drosophila wing. Curr Biol (1999) 1.39
Acetylcholine receptors in human thymic myoid cells in situ: an immunohistological study. Ann Neurol (1987) 1.38
The COE--Collier/Olf1/EBF--transcription factors: structural conservation and diversity of developmental functions. Mech Dev (2001) 1.38
Comparisons of proteins associated with duck-globin mRNA and its polyadenylated segment in polyribosomal and repressed free messenger ribonucleoprotein complexes. Eur J Biochem (1981) 1.37
Collier, a novel regulator of Drosophila head development, is expressed in a single mitotic domain. Curr Biol (1996) 1.36
AChR phosphorylation and indirect inhibition of AChR function in seronegative MG. Neurology (2002) 1.35
The estrogen receptor locus is associated with a major gene influencing litter size in pigs. Proc Natl Acad Sci U S A (1996) 1.33
Mutations in different functional domains of the human muscle acetylcholine receptor alpha subunit in patients with the slow-channel congenital myasthenic syndrome. Hum Mol Genet (1997) 1.33
Postsynaptic abnormalities at the neuromuscular junctions of utrophin-deficient mice. J Cell Biol (1997) 1.33
Acetylcholine receptor antibody characteristics in myasthenia gravis. II. Patients with penicillamine-induced myasthenia or idiopathic myasthenia of recent onset. Clin Exp Immunol (1982) 1.32
Spontaneous healing of aneurysmal bone cysts. A report of three cases. J Bone Joint Surg Br (1989) 1.32
Male pregnancy in seahorses and pipefishes (family Syngnathidae): rapid diversification of paternal brood pouch morphology inferred from a molecular phylogeny. J Hered (2001) 1.32
Limbic encephalitis associated with antibodies to the NMDA receptor in Hodgkin lymphoma. Neurology (2009) 1.30
The serendipity alpha gene encodes a membrane-associated protein required for the cellularization of the Drosophila embryo. Genes Dev (1990) 1.30
Development of innervation of skeletal muscle fibers in man: relation to acetylcholine receptors. Anat Rec (1993) 1.28
Family of Ebf/Olf-1-related genes potentially involved in neuronal differentiation and regional specification in the central nervous system. Dev Dyn (1997) 1.27
Opsoclonus-myoclonus syndrome associated with benign ovarian teratoma. Neurology (2008) 1.27
Limbic encephalitis in children and adolescents. Arch Dis Child (2010) 1.26
FDG-PET hyperactivity in basal ganglia correlating with clinical course in anti-NDMA-R antibodies encephalitis. J Neurol Neurosurg Psychiatry (2010) 1.26
Physiological control of smooth muscle-specific gene expression through regulated nuclear translocation of serum response factor. J Biol Chem (2000) 1.26
Myasthenia gravis and neuromyelitis optica spectrum disorder: a multicenter study of 16 patients. Neurology (2012) 1.25
Mature, long-lived CD4+ and CD8+ T cells are generated by the thymoma in myasthenia gravis. Ann Neurol (2001) 1.25
Anti-glial nuclear antibody: marker of lung cancer-related paraneoplastic neurological syndromes. J Neuroimmunol (2005) 1.24
Myasthenia gravis: population differences in disease expression and acetylcholine receptor antibody titers between Chinese and Caucasians. Neurology (1987) 1.24
Neuromuscular transmission after immunization against acetylcholine receptors. Proc R Soc Lond B Biol Sci (1975) 1.22
Course and outcome of acute limbic encephalitis with negative voltage-gated potassium channel antibodies. J Neurol Neurosurg Psychiatry (2006) 1.22
Spontaneous neutralising antibodies to interferon--alpha and interleukin-12 in thymoma-associated autoimmune disease. Lancet (1997) 1.22
Soluble complement receptor 1 (sCR1) protects against experimental autoimmune myasthenia gravis. J Neuroimmunol (1996) 1.21
Myasthenia gravis without acetylcholine-receptor antibody: a distinct disease entity. Lancet (1986) 1.20
Anti-acetylcholine receptor antibodies. J Neurol Neurosurg Psychiatry (1980) 1.20
Toward a physical map of the Xq28 region in man: linking color vision, G6PD, and coagulation factor VIII genes to an X-Y homology region. Genomics (1989) 1.19
Progressive encephalomyelitis with rigidity and myoclonus: resolution after thymectomy. Neurology (2011) 1.19
Sequential antibodies to potassium channels and glutamic acid decarboxylase in neuromyotonia. Neurology (2005) 1.18
Acetylcholine receptor antibody synthesis by thymic lymphocytes: correlation with thymic histology. Neurology (1981) 1.17
Mother's little helpers: Patterns of male care in mammals. Trends Ecol Evol (1994) 1.17
XCoe2, a transcription factor of the Col/Olf-1/EBF family involved in the specification of primary neurons in Xenopus. Curr Biol (1998) 1.16
Requirement for the Drosophila COE transcription factor Collier in formation of an embryonic muscle: transcriptional response to notch signalling. Development (1999) 1.15
A randomized trial of 3,4-diaminopyridine in Lambert-Eaton myasthenic syndrome. Neurology (2000) 1.15
The human muscle nicotinic acetylcholine receptor alpha-subunit exist as two isoforms: a novel exon. EMBO J (1990) 1.15
Alpha7-acetylcholine receptor antibodies in two patients with Rasmussen encephalitis. Neurology (2005) 1.14
Primary structure of the human muscle acetylcholine receptor. cDNA cloning of the gamma and epsilon subunits. Eur J Biochem (1993) 1.14
Evidence for a translational inhibitor linked to globin mRNA in untranslated free cytoplasmic messenger ribonucleoprotein complexes. FEBS Lett (1976) 1.13
Rapsyn mutations in hereditary myasthenia: distinct early- and late-onset phenotypes. Neurology (2003) 1.13
Dramatic inhibition of amiodarone metabolism induced by grapefruit juice. Br J Clin Pharmacol (2000) 1.13
Botulinum toxin type B: a double-blind, placebo-controlled, safety and efficacy study in cervical dystonia. Neurology (1997) 1.12
Neoadjuvant chemotherapy in ER+ HER2- breast cancer: response prediction based on immunohistochemical and molecular characteristics. Breast Cancer Res Treat (2011) 1.12
Autoimmunity to the voltage-gated calcium channel underlies the Lambert-Eaton myasthenic syndrome, a paraneoplastic disorder. Trends Neurosci (1989) 1.12